Regulatory and Scientific Aspects of Drug-Drug Interaction Studies

被引：1
|
作者：
Greenblatt, David J. [1 ]
机构：
[1] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT | 2012年 / 1卷 / 02期
关键词：
D O I：
10.1177/2160763X12440803
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：43 / +
页数：2
相关论文
共 50 条
  • [41] How Far Should We Go? Perspective of Drug-Drug Interaction Studies in Drug Development
    Kusuhara, Hiroyuki
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (03) : 227 - 228
  • [42] Drug-drug Interaction Studies Investigating the Impact of Levonorgestrel on Antiviral Potency of Dapivirine
    Evans, Abbey B.
    Holt, Jonathon
    Nuttall, Jeremy
    Shattock, Robin
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A137 - A137
  • [43] Best Practices for the Use of Itraconazole as a Replacement for Ketoconazole in Drug-Drug Interaction Studies
    Liu, Lichuan
    Bello, Akintunde
    Dresser, Mark J.
    Heald, Donald
    Komjathy, Steven Ferenc
    O'Mara, Edward
    Rogge, Mark
    Stoch, S. Aubrey
    Robertson, Sarah M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (02): : 143 - 151
  • [44] Most common interactant drugs in drug-drug interaction (DDI) studies.
    Uppoor, RS
    Marroum, P
    Burnett, A
    Ajayi, F
    Yuan, R
    Svadjian, R
    Balian, JD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 147 - 147
  • [45] Methodological Considerations on the Use of Cohort Designs in Drug-Drug Interaction Studies in Pharmacoepidemiology
    Dimakos, Jenny
    Douros, Antonios
    CURRENT EPIDEMIOLOGY REPORTS, 2024, 11 (03) : 175 - 183
  • [46] A Case to Support the Continued Use of Rifampin in Clinical Drug-Drug Interaction Studies
    Bercu, Joel P.
    Ponting, David J.
    Ripp, Sharon L.
    Dobo, Krista L.
    Totah, Rheem A.
    Bolleddula, Jayaprakasam
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (01) : 34 - 37
  • [47] Cyclosporine exacerbates ketamine toxicity in zebrafish: Mechanistic studies on drug-drug interaction
    Robinson, Bonnie L.
    Dumas, Melanie
    Ali, Syed F.
    Paule, Merle G.
    Gu, Qiang
    Kanungo, Jyotshna
    JOURNAL OF APPLIED TOXICOLOGY, 2017, 37 (12) : 1438 - 1447
  • [48] Population pharmacokinetic drug-drug interaction analyses of rufinamide studies in patients with epilepsy
    Fuseau, E
    Critchley, D
    Perdomo, C
    Arroyo, S
    EPILEPSIA, 2005, 46 : 210 - 211
  • [49] Drug-drug interaction from the standpoint of pharmacokineties
    Ohdo, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 28P - 28P
  • [50] Opioid metabolism and drug-drug interaction in cancer
    Aapro, Matti
    Fogli, Stefano
    Morlion, Bart
    Danesi, Romano
    ONCOLOGIST, 2024, 29 (11): : 931 - 942
12345